Park National Corp OH Buys 1,776 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Park National Corp OH boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,273 shares of the company’s stock after purchasing an additional 1,776 shares during the quarter. Park National Corp OH’s holdings in HCA Healthcare were worth $8,786,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Savant Capital LLC grew its holdings in HCA Healthcare by 68.6% during the 2nd quarter. Savant Capital LLC now owns 3,454 shares of the company’s stock worth $1,110,000 after acquiring an additional 1,405 shares in the last quarter. Acadian Asset Management LLC increased its holdings in HCA Healthcare by 108.2% during the second quarter. Acadian Asset Management LLC now owns 7,021 shares of the company’s stock valued at $2,253,000 after buying an additional 3,649 shares during the period. Ashton Thomas Private Wealth LLC purchased a new stake in HCA Healthcare during the second quarter worth $49,000. Prudential PLC raised its position in shares of HCA Healthcare by 143.7% in the 2nd quarter. Prudential PLC now owns 17,715 shares of the company’s stock worth $5,691,000 after acquiring an additional 10,447 shares in the last quarter. Finally, Choreo LLC bought a new stake in HCA Healthcare during the second quarter valued at about $1,799,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HCA. Truist Financial lowered their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday. Oppenheimer upped their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. TD Cowen dropped their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Morgan Stanley lowered their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Finally, Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.27.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by company insiders.

HCA Healthcare Trading Up 3.9 %

Shares of NYSE:HCA opened at $308.55 on Wednesday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The business has a 50 day moving average of $324.68 and a two-hundred day moving average of $354.48. HCA Healthcare, Inc. has a 12-month low of $276.50 and a 12-month high of $417.14. The company has a market capitalization of $78.15 billion, a PE ratio of 13.85, a PEG ratio of 1.21 and a beta of 1.64.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.